AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇷🇼
HYOSCINE BUTYLBROMIDE in Rwanda
4 products registered with RDA — 4 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| HYOSWISS Solution for Injection | Rwanda FDA-HMP-MA-2305 | SWISS PARENTERALS LTD | active | 11 May 2030 |
| HYOSCINE BUTYLBROMIDE TABLETS | Rwanda FDA-HMP-MA-2235 | COSMOS LIMITED | active | 3 Feb 2030 |
| Hyoscine Butylbromide Tablets BP 10mg Tablets | Rwanda FDA-HMP-MA-2063 | ANGEL BIOGENICS PVT. LTD | active | 29 Sept 2029 |
| BUSCOMAX Tablets | Rwanda FDA-HMP-MA-1760 | MAXTAR BIO-GENICS | active | 16 Aug 2029 |
HYOSCINE BUTYLBROMIDE — RDA Registration Details
RDA (Rwanda) has 4 registered products containing HYOSCINE BUTYLBROMIDE, of which 4 are currently active. Data is sourced directly from the official RDA drug register and refreshed daily.
Track HYOSCINE BUTYLBROMIDE registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.